270 related articles for article (PubMed ID: 20422943)
21. Fixed-dose combination lercanidipine/enalapril.
Hair PI; Scott LJ; Perry CM
Drugs; 2007; 67(1):95-106; discussion 107-8. PubMed ID: 17209666
[TBL] [Abstract][Full Text] [Related]
22. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
Applegate W; Cohen JD; Wolfson P; Davis A; Green S
Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
[TBL] [Abstract][Full Text] [Related]
23. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
Cicero AF; Gerocarni B; Rosticci M; Borghi C
Clin Exp Hypertens; 2012; 34(2):113-7. PubMed ID: 21967031
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
[TBL] [Abstract][Full Text] [Related]
25. [Effect of Fixed Lercanidipine/Enalapril Combination on 24-Hour Blood Pressure Proffie in Elderly Patients With Arterial Hypertension].
Gosteva EV; Vasil'eva LV
Kardiologiia; 2015; 55(2):32-6. PubMed ID: 26164986
[TBL] [Abstract][Full Text] [Related]
26. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
[TBL] [Abstract][Full Text] [Related]
27. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
28. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of arteril hypertension in patients with chronic kidney disease: a fixed combination of lercanidipine and enalapril].
Minushkina LO
Kardiologiia; 2013; 53(12):64-9. PubMed ID: 24800484
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of lercanidipine/enalapril fixed combination in Lebanon: a prospective observational study.
Arnaout S;
Curr Med Res Opin; 2015 Jan; 31(1):187-90. PubMed ID: 25424779
[TBL] [Abstract][Full Text] [Related]
31. Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial.
Mancia G; Coca A; Chazova I; Girerd X; Haller H; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
J Hypertens; 2014 Aug; 32(8):1700-7; discussion 1707. PubMed ID: 24906174
[TBL] [Abstract][Full Text] [Related]
32. Fixed-dose lercanidipine/enalapril for hypertension.
Menne J; Haller H
Drugs Today (Barc); 2008 Apr; 44(4):261-70. PubMed ID: 18536784
[TBL] [Abstract][Full Text] [Related]
33. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216
[TBL] [Abstract][Full Text] [Related]
34. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of lercanidipine in the general practice setting].
Robles NR; Canelada JA; Iglesias M; Angulo E; López Acedo A; Díaz Olea E; Cidoncha F; Guerras M; Fuentes J; Garrido J; Lapie J; Peña J; Aguilar A; Hidalgo P
An Med Interna; 2003 Jun; 20(6):282-6. PubMed ID: 12848597
[TBL] [Abstract][Full Text] [Related]
36. Fixed-dose lercanidipine and enalapril in field practice: a meta-analysis.
Rizzoni D
Curr Med Res Opin; 2016 Oct; 32(sup2):13-15. PubMed ID: 27779457
[TBL] [Abstract][Full Text] [Related]
37. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.
De Ciuceis C; Salvetti M; Rossini C; Muiesan ML; Paini A; Duse S; La Boria E; Semeraro F; Cancarini A; Rosei CA; Sarkar A; Ruggeri G; Caimi L; Ricotta D; Rizzoni D; Rosei EA
J Hypertens; 2014 Mar; 32(3):565-74. PubMed ID: 24378999
[TBL] [Abstract][Full Text] [Related]
38. Nitrendipine and enalapril combination therapy in mild to moderate hypertension: assessment of dose-response relationship by a clinical trial of factorial design.
Roca-Cusachs A; Torres F; Horas M; Ríos J; Calvo G; Delgadillo J; Terán M;
J Cardiovasc Pharmacol; 2001 Dec; 38(6):840-9. PubMed ID: 11707687
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
Rosei EA; Rizzoni D;
J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
